Merck's latest earnings call revealed a mix of growth and pain points for the pharmaceutical giant.

CNBC’s Deirdre Bosa, Big Technology’s Alex Kantrowitz and Wealth Enhancement’s Ayako Yoshioka, join 'Closing Bell' to discuss ...

Hundreds of thousands of doses of moxidectin – which treats a disease caused by a parasitic worm – are being given to ...

I worked closely with NCI’s Investigational Drug Branch (IDB) from 1990-2016, including as a principal investigator of one of ...

Konstanz biologist Patrick Müller receives a Proof of Concept Grant from the European Research Council for his project "EmbryoNet-AI". Its goal is the further development of an AI-supported platform ...

Three sectors stand out for their exceptional potential: defense, energy, and pharmaceuticals. This momentum is represented in the pharmaceutical industry, where research laboratories still buy ...

CHATHAM, N.J. - Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), a biopharmaceutical company with a market capitalization ...

A Lloyd's of London company partnered with GATC Health to fund and insure prospective drug trials that pass the test of a new AI technology.

New heart health biopharmaceutical company Kardigan, which counts among its co-founders the director for Northwestern ...

Patients taking Novo Nordisk’s Wegovy plus Veru’s enobosarm saw 71% lower lean mass loss than those who were taking Wegovy ...

Ardena assists biopharmaceutical companies in navigating through the drug discovery and development process, by providing ...